Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

Colin C. Pritchard, Joaquı́n Mateo, Michael F. Walsh, +40

New England Journal of Medicine

Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

Akash Kumar, Ilsa M. Coleman, Colm Morrissey, +20

Nature Medicine

Disease HeterogeneityMetastatic Prostate CancerUrologyGenitourinary CancerTumor Heterogeneity +5

Quantifying the role of PSA screening in the US prostate cancer mortality decline

Ruth Etzioni, Alex Tsodikov, Angela B. Mariotto, +8

Cancer Causes & Control

UrologyPreventive MedicineCancer ScreeningMedicineEpidemiology Of Cancer +3

Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling

Lauren Brady, Michelle Kriner, Ilsa M. Coleman, +12

Nature Communications

Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress

Michael D. Nyquist, Alexandra Corella, Ilsa M. Coleman, +14

Cell Reports

Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening Strategies

Roman Gulati, John L. Gore, Ruth Etzioni

Annals of Internal Medicine

Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits

Iris Lansdorp‐Vogelaar, Roman Gulati, Angela B. Mariotto, +14

Annals of Internal Medicine

The prostate cancer conundrum revisited

Ruth Etzioni, Roman Gulati, Alex Tsodikov, +8

Cancer

Cancer Outcomes in DCIS Patients Without Locoregional Treatment

Marc D. Ryser, Donald L. Weaver, Fengmin Zhao, +7

JNCI Journal of the National Cancer Institute

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer

Michael T. Schweizer, Kathleen Haugk, Jožefa S. McKiernan, +9

PLoS ONE